Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary presents a positive outlook with strong financial performance, optimistic guidance, and strategic investments in technology and market expansion. The Q&A section highlights positive trends in HSA adoption and member engagement, with management addressing macroeconomic challenges effectively. Share repurchase plans and capital return strategies further bolster investor confidence. Despite some unclear responses, the overall sentiment is positive, with promising market opportunities and growth potential.
Adjusted EBITDA growth 23% growth year-over-year in the fourth quarter, with more than 500 basis points of adjusted EBITDA margin expansion. This reflects strong execution and operational leverage.
HSA Accounts Added a record 550,000 HSAs in the fourth quarter, resulting in more than 1 million new HSAs for the year, bringing total accounts to 17.8 million. This growth reflects strong demand for HSAs and effective distribution.
HSA Assets Increased 14% year-over-year to more than $36 billion. This growth is attributed to higher balances per member and deeper engagement.
Revenue Grew 7% year-over-year to $334.6 million in the fourth quarter. This growth is driven by increased custodial revenue and interchange revenue.
Net Income Increased 89% year-over-year to $49.7 million in the fourth quarter. This reflects meaningful margin expansion and reduced fraud costs.
Non-GAAP Net Income Increased 33% year-over-year, with non-GAAP net income per diluted share growing 38%. This reflects operational efficiency and margin expansion.
Gross Margin Expanded to 68% in the fourth quarter, up from 61% last year, reflecting reduced fraud costs and service efficiency.
Cash Flow from Operations Generated $457 million in fiscal 2026. This reflects strong operational performance and cash generation.
Share Repurchase Program Returned more than $300 million to shareholders in fiscal 2026, reducing diluted shares outstanding by approximately 3%. This reflects a focus on returning capital to shareholders.
Marketplace Launch: Expanded HSA usage by launching a marketplace with offerings like weight loss programs, hormone replacement therapy, and healthcare wearables. Early adoption shows strong retention rates.
AI Integration: Introduced AI tools to enhance member experience, operational efficiency, and personalization. AI-driven automation is reducing service costs and improving resolution speed.
Retail Healthcare Channel Expansion: Expanded HSA distribution into retail healthcare channels, enabling individuals to open and fund HSAs through mobile and web platforms. Targeting Bronze plan consumers on ACA exchanges.
Policy Environment: Legislation expanded HSA eligibility to Bronze plan consumers on ACA exchanges, creating new opportunities for growth.
HSA Growth: Added 1 million new HSAs in fiscal 2026, bringing total accounts to 17.8 million and HSA assets to over $36 billion. HSA investors grew 10% year-over-year.
Fraud Reduction: Reduced fraud costs significantly, achieving a fraud reimbursement exit run rate of 0.1 basis points in Q4, well below the target of 1 basis point annually.
Mobile Engagement: Achieved over 3.6 million downloads of the mobile app, reflecting increased digital engagement.
Share Repurchase Program: Returned over $300 million to shareholders in fiscal 2026, reducing diluted shares outstanding by approximately 3%.
AI as Earnings Engine: Positioning AI as a central component of the next-generation healthcare financial operating system to scale member engagement and reduce costs.
Regulatory Environment: Potential risks associated with changes in the regulatory environment, including the need to adapt to new laws and policies such as the Working Families Tax Cuts Act and other legislative changes that could impact HSA eligibility and adoption.
Fraud and Security: Despite progress in reducing fraud costs, there remains a risk of fraud and security breaches, which could impact member trust and financial performance.
Interest Rate Volatility: Exposure to interest rate volatility, which could affect custodial revenue and the performance of interest rate forward contracts.
AI Implementation: Challenges in embedding AI into operations, including ensuring responsible deployment, maintaining data security, and achieving the intended operational efficiencies.
Market Competition: Competitive pressures in the HSA and consumer-directed healthcare market, which could impact growth and market share.
Economic Conditions: Economic uncertainties that could affect consumer behavior, HSA contributions, and overall financial performance.
Operational Efficiency: Risks associated with achieving operational efficiency goals, including reliance on AI-driven automation and self-service capabilities.
Revenue Expectations: Revenue for fiscal 2027 is expected to be between $1.405 billion and $1.415 billion, reflecting strong execution and increased visibility into fiscal 2027 trajectory.
Net Income Projections: GAAP net income is expected to be between $239 million to $246 million, or $2.78 to $2.85 per share. Non-GAAP net income is projected to be between $392 million and $400 million, or $4.56 to $4.65 per share.
Adjusted EBITDA: Adjusted EBITDA is expected to be between $618 million and $628 million for fiscal 2027.
Custodial Yield: The average yield on HSA cash is expected to be approximately 3.8% for fiscal 2027, taking into account forward hedges and projected HSA cash deployments.
Capital Allocation: The company plans to continue share repurchases under the remaining $178 million repurchase authorization and may further reduce borrowings on its revolver during fiscal 2027.
Market Trends and Growth Drivers: The company anticipates continued revenue growth, sustained margin expansion, and disciplined investment in technology, security, and sales and marketing. It also expects to benefit from structural tailwinds such as increased HSA adoption and consumer-directed healthcare trends.
Share Repurchase Program: HealthEquity returned more than $300 million to shareholders through its share repurchase program in fiscal 2026, reducing diluted shares outstanding by approximately 3%. Additionally, the company repurchased approximately $82 million of its outstanding shares during the fourth quarter and over $300 million during fiscal 2026. There is approximately $178 million remaining on the previously announced share repurchase authorization. The company plans to continue share repurchases under the remaining authorization in fiscal 2027.
The earnings call summary presents a positive outlook with strong financial performance, optimistic guidance, and strategic investments in technology and market expansion. The Q&A section highlights positive trends in HSA adoption and member engagement, with management addressing macroeconomic challenges effectively. Share repurchase plans and capital return strategies further bolster investor confidence. Despite some unclear responses, the overall sentiment is positive, with promising market opportunities and growth potential.
The earnings call summary and Q&A indicate positive financial performance, strategic HSA market expansion, and efficiency improvements through AI and automation. Despite competitive pressures, the company maintains high retention rates and leverages a strong enterprise pipeline. The Bronze plan expansion adds significant growth potential, supported by positive analyst sentiment. While management avoided some specifics, optimistic guidance and strategic investments in technology and shareholder returns bolster a positive outlook.
The earnings call indicates strong operational efficiency and strategic advancements, such as AI and mobile enhancements, HSA growth, and fraud prevention. Despite some unclear management responses, the overall sentiment is positive, with optimistic guidance and improved service margins. The Q&A highlights proactive legislative engagement and market opportunities, reinforcing a positive outlook. The absence of negative financial surprises or guidance cuts further supports a positive stock price movement.
The earnings call summary shows strong financial performance with significant revenue growth, increased gross profit margin, and a robust share repurchase plan. The Q&A section reveals management's optimism about the pipeline and successful fraud prevention, though some responses were vague. The raised guidance and record HSA assets further enhance the positive outlook. Given these factors, a positive stock price movement is likely, despite potential macroeconomic concerns.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.